期刊文献+

国产与进口奥沙利铂在直肠癌术后化疗中的安全性与有效性的比较研究 被引量:2

Efficacy and Safety of Domestic vs. Imported Oxaliplatin Used in the Postoperative Chemotherapy for Rectal Cancer
下载PDF
导出
摘要 目的:探讨国产与进口奥沙利铂在直肠癌术后化疗中的安全性与有效性,指导临床用药。方法:对同期收治的TNMⅡ和Ⅲ期直肠癌患者共97例,随机分为国产奥沙利铂(奥沙利铂注射液)组52例,和进口奥沙利铂(乐沙定)组45例,进行术后辅助化疗,采用FOLFOX4方案,观察、记录患者的不良反应及术后局部复发、远处转移及生存情况,进行统计学分析。结果:两组患者化疗不良反应的差异无显著性意义(P>0.05),3年后的局部复发及存活率存在一定的差异。结论:国产奥沙利铂使用仍然是安全、有效的,其3年生存率较高;对有经济条件的患者,可以考虑使用进口奥沙利铂,对患者整体术后治疗是有益的。 OBJECTIVE:To study the efficacy and safety of the domestic vs.imported oxaliplatin applied in postoperative chemotherapy for rectal cancer so as to offer references for clinical medication.METHODS:A total of 97 concurrently admitted patients with TNM Ⅱ and Ⅲ rectal cancer were randomly assigned to either domestic oxaliplatin group(Oxaliplatin Injection,n = 52) or imported oxaliplatin group(Eloxatin,n = 45).Postoperative adjuvant chemotherapy with FOLFOX4 program was adopted.The adverse reactions,postoperative local recurrence,metastasis and survival rates were observed and recorded and a statistical analysis was conducted.RESULTS:There were no significant differences between the two groups with regard to the adverse reactions(P 0.05) whereas there were some certain differences in local recurrence at 3 years and survival rates.CONCLUSION:Domestic oxaliplatin is safe and effective with high three-year survival rates.However,the imported Oxaliplatin can be considered for those patients with good economic conditions for its beneficial efficacy for patient's postoperative holistic treatment.
出处 《中国医院用药评价与分析》 2010年第4期347-349,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 乐沙定 奥沙利铂 直肠肿瘤 化疗 Eloxatin Oxaliplatin Rectal cancer Chemotherapy
  • 相关文献

参考文献15

二级参考文献35

  • 1刘宁,种道群,袁蕾蕾,国桂松,黄建国.国产奥沙利铂联合亚叶酸钙和5-氟脲嘧啶治疗晚期结直肠癌的临床观察[J].临床肿瘤学杂志,2004,9(5):484-485. 被引量:6
  • 2翟艳辉,李莹,杨朝英,黎苗,董瑜.草酸铂联合氟尿嘧啶、甲酰四氢叶酸治疗晚期大肠癌临床疗效观察[J].现代肿瘤医学,2006,14(1):65-67. 被引量:15
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Extra JM, Espie M, Calvo F, et al. Phase I study of oxaliplatin in patients with advanced cancer [ J ]. Cancer Chemother Pharmacol, 1990,25 (4) : 299.
  • 5Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouraeil - leueovorin compared with either therapy alone in patients with progressive eoloreetal cancer after irinotecan and fluorouracil - leueovorin: interim results of a phase Ⅲ trial[J] . J Clin Oncol, 2003,21(11) :2 059.
  • 6Goldberg RM, Sargent D J, Morton RF, et al. A randomized controlled trial of iluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patientswith previously untreated metastatic colorectal cancer[ J ] . J Clin Oncol, 2004,22 ( 1 ) : 23.
  • 7Shlebak AA, Clark PI, Green JA. Hypersensitivity and cross reactivity to cisplatin and analogues [ J]. Cancer Chemother Pharmacol, 1995, 35(4) : 349.
  • 8Markman M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin [ J ]. J Clin Oncol , 1999, 17(4): 1 141.
  • 9Tournigand C, Maindrault - Goebel F, Louvet C, et al. Severe anaphylactic reactions to oxaliplatin [ J ]. Eur J Cancer, 1998,34(8) : 1 297.
  • 10Brandi G, Pantaleo MA, Galli C, et al . Hypersensitivity reactions related to oxaliplatin [ J ]. Br J Cancer, 2003,89 (3) :477.

共引文献371

同被引文献8

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部